Results 161 to 165 of about 21,581 (165)

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Supportive Care in Cancer, 2016
K. Jordan, A. Chan, R. Gralla, Franziska Jahn, B. Rapoport, D. Warr, P. Hesketh   +6 more
semanticscholar   +1 more source

Antineoplastic agents and thrombotic microangiopathy

Journal of Oncology Pharmacy Practice, 2017
Gwenalyn Garcia, J. Atallah
semanticscholar   +1 more source

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization

Allergy. European Journal of Allergy and Clinical Immunology, 2015
E. Álvarez-Cuesta, R. Madrigal-Burgaleta, D. Angel-Pereira, A. Ureña-Tavera, Miriam Zamora-Verduga, P. López-González, M. Berges-Gimeno   +6 more
semanticscholar   +1 more source

Antineoplastic Agents and the Associated Myelosuppressive Effects

Journal of pharmacy and practice, 2014
J. Barreto, Kristen B. McCullough, Lauren L. Ice, Judith A. Smith   +3 more
semanticscholar   +1 more source

Cardiotoxicity of Antineoplastic Agents: What Is the Present and Future Role for Imaging?

Current Oncology Reports, 2014
T. M. Markman, M. Markman
semanticscholar   +1 more source